Pierre Fabre group, the third largest French pharmaceutical company, has made its Research & Development a key element for its differentiation and a driving force for its growth in the medical field.
Based on a very active partnership policy, the Pierre Fabre Group concentrates its resources on research and development of original molecules, whether natural, chemical or biological for therapeutic uses.
Its Dexteryl Cream helps the signs and symptoms of xerosis associated with atopic dermatitis and ichthyosis. The emollient moisturising cream alleviates the discomfort of skin diseases and is easy to apply, quickly absorbed, and soothing.
Pierre Fabre Laboratories was founded in 1961 with a view to researching, developing and marketing dermatological drugs and cosmetics to suit the requirements of dermatologists.
Pierre Fabre looks after a portfolio of brands from Klorane to Ducray to Avène. Each of these seek to make the job of the dermatologist a little easier by blending beauty with the know-how and expertise of Pierre Fabre innovation. This rigorous approach is based upon the pharmaceutical culture of its laboratories, and the constant research that takes place as an inherent part of Pierre Fabre's philosophy.
The Dexteryl Cream is a key product. It offers treatment for the signs and symptops of skin dryness (xerosis) especially in various skin diseases (such as atopic dermatitis, ichtyosis). Launched in 2008, it was specifically formulation to soothe skin stresses.